Association of age and overall survival in capecitabine-treated patients with metastatic breast cancer in clinical trials

By Blum Joanne   Kohles Joseph   McKenna Edward   Scotto Nana   Hu Sylvia   Odom Dawn   Kaye James   Glück Stefan  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 431-439

Springer Publishing Company

Access to resources Recommend Favorite

Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients

By Ferraldeschi Roberta  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 1191-1198

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Evaluation of the Use of Exemestane as Further Hormonal Therapy after Nonsteroidal Aromatase Inhibitors in Postmenopausal Metastatic Breast Cancer Patients

By Carlini Paolo   Michelotti Andrea   Ferretti Gianluigi   Ricci Sergio   Giannarelli Diana   Pellegrini Manuela   Cresti Nicola   Cosimo Serena Di   Bria Emilio   Papaldo Paola   Fabi Alessandra   Ruggeri Enzo Maria   Milella Michele   Alimonti Andrea   Salesi Nello   Cognetti Francesco  

Cancer Investigation, Vol. 25, Iss. 2, 2007-03 ,pp. : 102-105

Informa Healthcare

Access to resources Recommend Favorite

Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer

By Hurvitz Sara   Lalla Deepa   Crosby Ross   Mathias Susan  

Breast Cancer Research and Treatment, Vol. 142, Iss. 3, 2013-12 ,pp. : 603-609

Springer Publishing Company

Access to resources Recommend Favorite

Surgical Removal of the Primary Tumor Increases Overall Survival in Patients With Metastatic Breast Cancer: Analysis of the 1988–2003 SEER Data

By Gnerlich Jennifer   Jeffe Donna   Deshpande Anjali   Beers Courtney   Zander Christina   Margenthaler Julie  

Annals of Surgical Oncology, Vol. 14, Iss. 8, 2007-08 ,pp. : 2187-2194

Springer Publishing Company

Access to resources Recommend Favorite